Internet Archive Scholar

Is it possible to use the Toll-like receptors as biomarkers for neonatal sepsis? Review of the recent literature

Irina Melinda Baizat, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Corina Gabriela Zaharie, Monica Hasmasanu, Melinda Matyas, Lucia Maria Procopciuc, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Neonatology I, County Emergency Hospital, Cluj-Napoca, Romania, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Neonatology I, County Emergency Hospital, Cluj-Napoca, Romania, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Neonatology I, County Emergency Hospital, Cluj-Napoca, Romania (+1 others)
2022 Romanian Journal of Pediatrics  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (363.7 kB)
https://web.archive.org/web/20221225164414/https://rjp.com.ro/articles/2022.3/RJP_2022_3_Art-01.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL. The file type is application/pdf.

Background. Sepsis continues to be one of the main death causes in the neonate population. The toll-like receptors are molecules that express in the plasma or endosomal membrane and recognize endosomal or microorganism components. While aiming at the identification of new neonatal sepsis biomarkers, the toll-like receptors (TLR) have been considered that some of them overexpress in contact with the bacterial components. Methods. Research in the PubMed database has been made by the following
more » ... eria: Inclusion criteria (PubMed database, Period 2005-2022, English & Humans, generated 29, Meta-Analysis - 0, Review - 6, Systematic Review - 0), Exclusion criteria (Studies on animal models, Articles with merely didactical content, Articles regarding only one of the words researched either only neonatal sepsis or TLR in another context than together, Articles that are not directly connected with the topic). Based on the above-mentioned criteria 13 articles were consulted, of which 7 articles included in vivo studies, 6 with in vitro studies. Conclusions. The data of the present review and the current diagnostic method point at the fact that TLRs increase in the conditions of the presence of the inflammatory syndrome. Their dosing during in the neonatal sepsis is possible, but the non-specific overexpression is not a diagnostic.
doi:10.37897/rjp.2022.3.1 fatcat:uqr3sqf7sncstfakynt6tv6cty
DOAJ
Citation

Irina Melinda Baizat, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Corina Gabriela Zaharie, Monica Hasmasanu, Melinda Matyas, Lucia Maria Procopciuc, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Neonatology I, County Emergency Hospital, Cluj-Napoca, Romania, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Neonatology I, County Emergency Hospital, Cluj-Napoca, Romania, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania, Department of Neonatology I, County Emergency Hospital, Cluj-Napoca, Romania, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania. "Is it possible to use the Toll-like receptors as biomarkers for neonatal sepsis? Review of the recent literature." Romanian Journal of Pediatrics 71.3 (2022) 105-111